A cytolytic RXT-toxin from Gallibacterium anatis

Anders Miki Bojesen; Bodil Marie Kristensen

A cytolytic RXT-toxin from Gallibacterium anatis

Anders Miki Bojesen (Inventor), Bodil Marie Kristensen (Inventor)

Abstract

New isolated polypeptide, comprising amino acid sequence including specific sequences or its variant, and fragment consisting of specific number of contiguous amino acids, to e.g. treat disease caused by bacterial infection in e.g. Anas

Original language	English
Patent number	WO2011042026-A1
Filing date	01/06/2011
Country/Territory	United States
Publication status	Published - 2011

Access to Document

A cytolytic RXT-toxin from Gallibacterium anatisFinal published version, 3.65 MB

Cite this

@misc{018a0b10fec511de825d000ea68e967b,

title = "A cytolytic RXT-toxin from Gallibacterium anatis",

abstract = "New isolated polypeptide, comprising amino acid sequence including specific sequences or its variant, and fragment consisting of specific number of contiguous amino acids, to e.g. treat disease caused by bacterial infection in e.g. Anas",

author = "Bojesen, {Anders Miki} and Kristensen, {Bodil Marie}",

year = "2011",

language = "English",

type = "Patent",

note = "WO2011042026-A1",

}

TY - PAT

T1 - A cytolytic RXT-toxin from Gallibacterium anatis

AU - Bojesen, Anders Miki

AU - Kristensen, Bodil Marie

PY - 2011

Y1 - 2011

N2 - New isolated polypeptide, comprising amino acid sequence including specific sequences or its variant, and fragment consisting of specific number of contiguous amino acids, to e.g. treat disease caused by bacterial infection in e.g. Anas

AB - New isolated polypeptide, comprising amino acid sequence including specific sequences or its variant, and fragment consisting of specific number of contiguous amino acids, to e.g. treat disease caused by bacterial infection in e.g. Anas

M3 - Patent

M1 - WO2011042026-A1

Y2 - 2011/06/01

ER -